The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
The Olympic and World champion seem unfazed by the electric vehicle which sent him flying in Beijing.
The rapper declared his intention to run at the end of a rambling acceptance speech at the VMAs last night.
As we see in the end of August, we mark the meteorological end of summer 2015.